{"Countermeasures": [0], "to": [1, 30, 40, 52, 61, 71, 130], "prevent": [2], "and": [3, 47, 70, 85, 119], "treat": [4], "coronavirus": [5, 23], "disease": [6, 102], "2019": [7], "(COVID-19)": [8], "are": [9], "a": [10, 16, 97, 113], "global": [11], "health": [12], "priority.": [13], "We": [14, 55], "enrolled": [15], "cohort": [17], "of": [18, 96, 122], "severe": [19], "acute": [20], "respiratory": [21], "syndrome": [22], "2": [24], "(SARS-CoV-2)-recovered": [25], "participants,": [26], "developed": [27], "neutralization": [28], "assays": [29], "investigate": [31], "antibody": [32, 37], "responses,": [33], "adapted": [34], "our": [35], "high-throughput": [36], "generation": [38], "pipeline": [39], "rapidly": [41], "screen": [42], "more": [43], "than": [44], "1800": [45], "antibodies,": [46], "established": [48], "an": [49], "animal": [50], "model": [51], "test": [53], "protection.": [54], "isolated": [56], "potent": [57], "neutralizing": [58], "antibodies": [59], "(nAbs)": [60], "two": [62], "epitopes": [63, 74, 129], "on": [64, 75], "the": [65, 76, 93], "receptor": [66], "binding": [67], "domain": [68], "(RBD)": [69], "distinct": [72], "non-RBD": [73], "spike": [77], "(S)": [78], "protein.": [79], "As": [80], "indicated": [81], "by": [82], "maintained": [83], "weight": [84], "low": [86], "lung": [87], "viral": [88], "titers": [89], "in": [90, 103, 107, 117], "treated": [91], "animals,": [92], "passive": [94], "transfer": [95], "nAb": [98], "provides": [99], "protection": [100], "against": [101], "high-dose": [104], "SARS-CoV-2": [105], "challenge": [106], "Syrian": [108], "hamsters.": [109], "The": [110, 124], "study": [111], "suggests": [112], "role": [114], "for": [115], "nAbs": [116, 125], "prophylaxis,": [118], "potentially": [120], "therapy,": [121], "COVID-19.": [123], "also": [126], "define": [127], "protective": [128], "guide": [131], "vaccine": [132], "design.": [133]}